Agile Therapeutics, Inc.
AGRX
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.86M | -7.79M | -14.47M | -13.93M | -19.06M |
| Total Depreciation and Amortization | 403.00K | 396.00K | 386.00K | 377.00K | 541.00K |
| Total Amortization of Deferred Charges | 612.00K | 891.00K | 1.06M | 1.17M | 1.76M |
| Total Other Non-Cash Items | 3.97M | -6.66M | -3.98M | -7.90M | -6.89M |
| Change in Net Operating Assets | 9.16M | 2.71M | 7.42M | 8.97M | -4.73M |
| Cash from Operations | -1.71M | -10.46M | -9.58M | -11.31M | -28.38M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.68M | -2.96M | -1.35M | -1.08M | -12.89M |
| Issuance of Common Stock | 4.45M | 11.61M | 8.24M | 9.12M | 31.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -1.00K | -1.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.77M | 8.65M | 6.89M | 8.04M | 18.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 1.00K | -- |
| Net Change in Cash | 64.00K | -1.81M | -2.69M | -3.27M | -10.24M |
